Exercise Therapy for Patients With Muscle Dystrophies

Status Recruiting

Clinical Trial Summary

Muscular Dystrophies (MD) are a heterogeneous group of diseases characterised by muscle wasting that lead to progressive loss of function. Although exercise training has been traditionally neglected to these patients due to concerns regarding muscle damage, research has shown that exercise therapy is safe and tolerable in this population and can lead to potential gains in endurance and muscle strength, as well as other patient-reported outcomes such as health-related quality of life.Therefore, in this study, the investigators aim to examine the feasibility, tolerability and safety as well as the effects of a 12-week, exercise-training program in patients with MD on functional capacity, muscle strength, and health-related quality of life.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscular Dystrophies

Clinical Trial Details

NCT number	NCT05081791
Study type	Interventional
Source	Universitat Pompeu Fabra
Contact	Raquel Sebio, PhD
Phone	+34679336288
Email	sebio@clinic.cat
Status	Recruiting
Phase	N/A
Start date	July 12, 2022
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01480245` - Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy	Phase 3
Completed	`NCT01153932` - Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy	Phase 2
Completed	`NCT00027391` - Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT03851107` - The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities	N/A
Completed	`NCT01462292` - A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)	Phase 2
Recruiting	`NCT06094205` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)	N/A
Recruiting	`NCT05724173` - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia	N/A
Recruiting	`NCT03698149` - ECoG BMI for Motor and Speech Control	N/A
Active, not recruiting	`NCT03811301` - [BrainConnexion] - Neurodevice Phase I Trial	N/A
Completed	`NCT05881122` - Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability	N/A
Completed	`NCT04154098` - Evaluation of a Textile Scapula Orthosis	N/A
Recruiting	`NCT05409079` - Schulze Muscular Dystrophy Ability Clinical Study	N/A
Enrolling by invitation	`NCT04009408` - Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders	N/A
Active, not recruiting	`NCT00674843` - The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies	Phase 1
Recruiting	`NCT02109692` - Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies	N/A
Active, not recruiting	`NCT04045158` - Diaphragm Ultrasound in Neuromuscular Disorders
Not yet recruiting	`NCT03508583` - Turkish Version of The Measure of Processes of Care (MPOC)
Terminated	`NCT01803412` - A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects	Phase 3
Completed	`NCT03406780` - A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy	Phase 2